CapitalRankings
  • Money
  • Banking
  • Investment
  • Trading
  • World News
  • Business
☰
✖
  • Money
  • Banking
  • Investment
  • Trading
  • World News
  • Business

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

The lawsuits come as Eli Lilly grapples with a shortage of Mounjaro in the U.S. due to skyrocketing demand.
READ FULL ARTICLE

Related posts

Automakers question UAW’s strike motives after leaked ‘chaos’ messages


Read more

UAW targets 38 facilities at GM and Stellantis for expanded strikes, skips Ford


Read more

    CATEGORIES

    • Banking
    • Business
    • Investment
    • Money
    • Trading
    • World News

    ARCHIVES

    LATEST POSTS

    • I took Finland’s free masterclass on happiness: Here are 3 things I learned
    • Tokenizing real-world assets on blockchains is for crypto lovers as well as crypto skeptics now
    • Scooter company Bird delisted from NYSE after stock collapse, will trade over the counter
    • Bill Gates: ‘Republicans for climate change action are gold’
    • Stocks making the biggest moves midday: Ford, Scholastic, Squarespace, Deere and more

Signup for Alerts and Newsletters!

Exclusive Market-Impacting News & Reports.

Know what’s hot, what’s innovative, and where the deals are with deep news and reports coverage. Join us now!



    Recent posts

    • I took Finland’s free masterclass on happiness: Here are 3 things I learned
    • Tokenizing real-world assets on blockchains is for crypto lovers as well as crypto skeptics now
    • Scooter company Bird delisted from NYSE after stock collapse, will trade over the counter
    CapitalRankings
    720 999 W. Broadway
    Vancouver, BC
    V5Z1K3 Canada
    ©2022 Capital Rankings. All Rights Reserved. Privacy Policy

    Get Exclusive Market-Impacting News & Reports.

    Know what’s hot, what’s innovative, and where the deals are with in-depth news and reporting coverage.
    Join us now!





      Erhalten Sie exklusive, marktbeeinflussende Nachrichten und Berichte.

      Erfahren Sie, was angesagt ist, was innovativ ist und wo die Geschäfte laufen – mit ausführlichen Nachrichten und Berichten. Melden Sie sich jetzt an!